153 related articles for article (PubMed ID: 36186420)
1. A comprehensive analysis of G-protein-signaling modulator 2 as a prognostic and diagnostic marker for pan-cancer.
Hu LM; Ou XH; Shi SY
Front Genet; 2022; 13():984714. PubMed ID: 36186420
[No Abstract] [Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
[TBL] [Abstract][Full Text] [Related]
4. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
[TBL] [Abstract][Full Text] [Related]
5.
Wang C; Yin Y; Sun Z; Wang Y; Li F; Wang Y; Zhang Z; Chen X
Dis Markers; 2022; 2022():2334338. PubMed ID: 36479043
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
8. Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms.
Zhou X; Dang S; Jiang H; Gu M
J Gastrointest Oncol; 2021 Jun; 12(3):1164-1179. PubMed ID: 34295565
[TBL] [Abstract][Full Text] [Related]
9. Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma.
Zhao L; Fu X; Han X; Yu Y; Ye Y; Gao J
Cancer Cell Int; 2021 Jan; 21(1):80. PubMed ID: 33509222
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
Front Oncol; 2022; 12():947054. PubMed ID: 36505822
[TBL] [Abstract][Full Text] [Related]
11. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
12. Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study.
Ma X; Huang S; Shi H; Luo R; Luo B; Tan Z; Shi L; Zhang W; Yang W; Zhong X; Lü M; Chen X; Tang X
Eur J Med Res; 2023 Dec; 28(1):590. PubMed ID: 38098097
[TBL] [Abstract][Full Text] [Related]
13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
15. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
[TBL] [Abstract][Full Text] [Related]
16. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
Ding JT; Yu XT; He JH; Chen DZ; Guo F
Front Genet; 2022; 13():912003. PubMed ID: 35783266
[No Abstract] [Full Text] [Related]
17. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
[TBL] [Abstract][Full Text] [Related]
18. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
19. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
